The role of systemic high-dose cytarabine in the treatment of central nervous system leukemia clinical results in 46 patients
- 15 July 1993
- Vol. 72 (2) , 439-445
- https://doi.org/10.1002/1097-0142(19930715)72:2<439::aid-cncr2820720220>3.0.co;2-4
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Current Pharmacological Treatment Approaches to Central Nervous System LeukaemiaDrugs, 1991
- Therapy of CNS leukemia with intraventricular chemotherapy and low-dose neuraxis radiotherapy.Journal of Clinical Oncology, 1985
- Remission from central nervous system involvement in adults with acute leukemia effect of intensive therapy and prognostic factorsCancer, 1985
- Treatment of meningeal relapse in childhood acute lymphoblastic leukemia. I. Results of craniospinal irradiation.Journal of Clinical Oncology, 1984
- Successful treatment of meningeal leukemia using systemic high-dose cytosine arabinoside.Journal of Clinical Oncology, 1984
- High-dose cytosine arabinoside therapy for refractory leukemiaBlood, 1983
- Treatment of Overt CNS LeukaemiaPublished by Springer Nature ,1983
- The impact of isolated central nervous system relapse following initial complete remission in childhood acute lymphocytic leukemiaThe Journal of Pediatrics, 1980
- High dose cytosine arabinoside (HDARAC) in refractory acute leukemiaCancer, 1979
- Adult Central Nervous System LeukemiaSouthern Medical Journal, 1976